Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM66714
Volume:
10 |
8 |
Aug 2026
Pages:
1--
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Department of Pharmaceutical Analysis
Sri Vijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri
Department of Pharmaceutical Analysis
Sri Vijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri
Department of Pharmaceutical Analysis
Sri Vijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri
Department of Pharmaceutical Analysis
Sri Vijay Vidyalaya College of Pharmacy, Nallampalli, Dharmapuri
A comparative analytical study was carried out to determine and compare the drug content of three different marketed brands (Brand A, Brand B and Brand C) of Dapagliflozin (10 mg) and Pioglitazone (15 mg) tablets using UV spectrophotometry. The absorbance of the drug solutions was measured at 223 nm for Dapagliflozin and 234 nm for Pioglitazone in methanol, and the percentage assay of each brand was calculated against the labelled claim. The mean assay values obtained for Dapagliflozin were 97.33%, 97.87% and 98.50% for Brand A, Brand B and Brand C, respectively, while the corresponding mean assay values for Pioglitazone were 96.78%, 97.78% and 98.50%. All three brands complied with the pharmacopoeial acceptance limit of 90.0-110.0% of the labelled claim, with Brand C consistently showing the highest assay among the brands studied. The results confirm that UV spectrophotometry is a simple, rapid, precise and economical method suitable for the routine quality control and comparative evaluation of Dapagliflozin and Pioglitazone tablets available in the market.
KEYWORDS
The present study successfully compared three marketed brands each of Dapagliflozin (10 mg) and Pioglitazone (15 mg) tablets by UV spectrophotometry at 223 nm and 234 nm, respectively. The mean assay values obtained were 97.33%, 97.87% and 98.50% for Dapagliflozin, and 96.78%, 97.78% and 98.50% for Pioglitazone, in Brand A, Brand B and Brand C respectively, all of which complied with the pharmacopoeial acceptance limit of 90.0-110.0% of the labelled claim. Brand C consistently exhibited the highest drug content among the three brands studied. The results confirm that UV spectrophotometry is a simple, accurate, precise and economical analytical technique suitable for the routine quality control and comparative brand-to-brand evaluation of Dapagliflozin and Pioglitazone tablets. Further studies employing fully validated methods (linearity, accuracy, precision, LOD, LOQ as per ICH Q2(R1) guidelines) across a larger number of brands are recommended to strengthen these findings.
[1] Chitra KP, Eswaraiah MC, Basaveswara Rao MV. Unique UV spectrophotometric method for reckoning of dapagliflozin in bulk and pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Research. 2015;7(9):45-49. [2] Mante GV, Gupta KR, Hemke AT. Estimation of Dapagliflozin from its Tablet Formulation by UV-Spectrophotometry. Pharmaceutical Methods. 2017;8(2):102-107. [3] Patel T, Parikh R. Method Development, Validation and Forced Degradation Studies of Dapagliflozin and Pioglitazone Hydrochlorides in Synthetic Mixtures by RP-HPLC. International Journal of Trend in Scientific Research and Development. 2022;6(6):1858-1869. [4] Mohamed FH, Manikandan K, Lakshmi KS. UV Spectrophotometric Estimation of Pioglitazone using Multivariate Method in Bulk Drug and Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology. 2021;14(1):14-20. [5] Mahadik PS, Senthilkumar GP. Method development and validation of pioglitazone in bulk by using UV spectrophotometric method. Asian Journal of Biochemical and Pharmaceutical Research. 2012;2(1):159-164. [6] Kommana R, Rebecca SD. Development and validation of UV spectrophotometric method for determination of pioglitazone hydrochloride in bulk and its formulations. Der Pharmacia Lettre. 2013;5(1):269-278. [7] Sabbagh B, Lokesh B, Akouwah GA. Validated RP-HPLC and UV-Spectroscopy Methods for the Estimation of Dapagliflozin in Bulk and in Tablets. Indian Drugs. 2017;54(3):44-51. [8] Jani BR, Shah KV, Kapupara PP. Ultraviolet-spectrophotometric method for simultaneous estimation of dapagliflozin propanediol and metformin hydrochloride. Journal of Applied Pharmaceutical Science. 2019. [9] Vadla S, Putta V. UV-Spectrophotometric Method Development and Validation for Quantifying Dapagliflozin in Bulk and Pharmaceutical Formulations. [10] Yadav M, et al. Simultaneous Estimation of Dapagliflozin, Sitagliptin, and Metformin in Tablet Formulation by UV Spectroscopy. African Journal of Biomedical Research. 2024;27(1s).
Publication Date
8/12/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
4
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...